XB371

· Exelixis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XB371, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]